Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies
A Liou; J T Wahlstrom; C C Dvorak; B N Horn
Author Information: Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, CA, USA and
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.